Xiumei Ma

671 total citations
34 papers, 473 citations indexed

About

Xiumei Ma is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiumei Ma has authored 34 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Xiumei Ma's work include Esophageal Cancer Research and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer-related molecular mechanisms research (4 papers). Xiumei Ma is often cited by papers focused on Esophageal Cancer Research and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer-related molecular mechanisms research (4 papers). Xiumei Ma collaborates with scholars based in China, Norway and Singapore. Xiumei Ma's co-authors include Yongrui Bai, Wiguins Etienne, Gregory M. Palmer, Tuan Vo‐Dinh, Yang Liu, Chen-Ting Lee, Yulin Zhao, Brant A. Inman, Paolo Maccarini and Haiyan Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Xiumei Ma

31 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiumei Ma China 12 181 124 110 110 108 34 473
Elizabeth M. Gillies United States 12 142 0.8× 130 1.0× 58 0.5× 85 0.8× 69 0.6× 16 438
Yunwei Han China 13 293 1.6× 116 0.9× 86 0.8× 53 0.5× 166 1.5× 28 453
Almudena García‐Castaño Spain 11 193 1.1× 204 1.6× 188 1.7× 38 0.3× 58 0.5× 30 496
Mie Grunnet Denmark 7 318 1.8× 289 2.3× 267 2.4× 128 1.2× 124 1.1× 11 726
Yamin Zhang China 13 344 1.9× 139 1.1× 67 0.6× 79 0.7× 139 1.3× 26 561
Kosuke Fujino Japan 13 177 1.0× 227 1.8× 280 2.5× 110 1.0× 58 0.5× 43 627
Yuejuan Xu China 13 189 1.0× 153 1.2× 152 1.4× 42 0.4× 181 1.7× 20 499
Yipeng Song China 17 237 1.3× 129 1.0× 265 2.4× 29 0.3× 169 1.6× 49 689
Songbing Qin China 14 179 1.0× 440 3.5× 206 1.9× 127 1.2× 92 0.9× 54 789

Countries citing papers authored by Xiumei Ma

Since Specialization
Citations

This map shows the geographic impact of Xiumei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiumei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiumei Ma more than expected).

Fields of papers citing papers by Xiumei Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiumei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiumei Ma. The network helps show where Xiumei Ma may publish in the future.

Co-authorship network of co-authors of Xiumei Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiumei Ma. A scholar is included among the top collaborators of Xiumei Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiumei Ma. Xiumei Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Lei, Jinhai Tang, Huiming Li, et al.. (2025). Neoadjuvant chemoradiotherapy combined with immunotherapy: a promising strategy for MSS/pMMR locally advanced rectal cancer. Medical Oncology. 42(10). 428–428.
3.
Fu, Jie, et al.. (2025). A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer. Frontiers in Pharmacology. 15. 1516735–1516735. 2 indexed citations
4.
Xing, Hui, Jun Zhang, Xiumei Ma, et al.. (2025). Scalable synthesis of high-energy–density fuels via highly-integrated domino annulation of biomass derived ketenes. Fuel. 389. 134566–134566. 1 indexed citations
5.
Zhang, Lei, Jun Ma, Jun Zhang, et al.. (2025). Radiotherapy‐Associated Cellular Senescence and EMT Alterations Contribute to Distinct Disease Relapse Patterns in Locally Advanced Cervical Cancer. Advanced Science. 12(12). e2412574–e2412574. 4 indexed citations
6.
Wang, Xiaohang, Xin Xu, Yuhui Huang, et al.. (2024). Predictive and prognostic value of ACSL4 and GPX4 in patients with esophageal squamous cell carcinoma receiving post-operative radiotherapy. Journal of Thoracic Disease. 16(12). 8317–8326.
8.
Wang, Yuming, Zhiyong Sun, Haiping Lin, et al.. (2022). Circular RNA hsa_circ_0003823 promotes the Tumor Progression, Metastasis and Apatinib Resistance of Esophageal Squamous Cell Carcinoma by miR-607/CRISP3 Axis. International Journal of Biological Sciences. 18(15). 5787–5808. 22 indexed citations
9.
Wang, Qing, Zhiyong Sun, Xin Xu, et al.. (2022). The Evaluation of a SEER-Based Nomogram in Predicting the Survival of Patients Treated with Neoadjuvant Therapy Followed by Esophagectomy. Frontiers in Surgery. 9. 853093–853093. 4 indexed citations
10.
Zhou, Jin, Haiping Lin, Xin Xu, et al.. (2022). The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy. Frontiers in Immunology. 13. 1041126–1041126. 10 indexed citations
11.
Hu, Bin, Xiumei Ma, Zheng Wu, et al.. (2021). Identification of Key Genes Mutations Associated With the Radiosensitivity by Whole Exome Sequencing in Pancreatic Cancer. Frontiers in Oncology. 11. 697308–697308. 6 indexed citations
12.
Liao, Keman, Xiumei Ma, Binghong Chen, et al.. (2018). Upregulated AHIF-mediated radioresistance in glioblastoma. Biochemical and Biophysical Research Communications. 509(2). 617–623. 11 indexed citations
13.
Zhang, Lei, Yueyao Du, Shuguang Xu, et al.. (2018). DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC. Cancer Letters. 442. 242–251. 50 indexed citations
14.
Liu, Yang, Paolo Maccarini, Gregory M. Palmer, et al.. (2017). Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers. Scientific Reports. 7(1). 8606–8606. 116 indexed citations
15.
Ma, Xiumei, et al.. (2017). P3.14-007 A Functional Equivalent Uniform Dose Correlates with Radiation Pneumonities in Radiation Therapy. Journal of Thoracic Oncology. 12(11). S2333–S2333. 1 indexed citations
16.
Chen, Haiyan, Xiumei Ma, Ming Ye, et al.. (2013). CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation. Journal of Radiation Research. 54(5). 938–942. 3 indexed citations
17.
Hou, Yanli, et al.. (2013). CT and MRI in target delineation in primary hepatocellular carcinoma. Cancer/Radiothérapie. 17(8). 750–754. 7 indexed citations
18.
Chen, Haiyan, et al.. (2013). Effectiveness and Toxicities of Intensity-Modulated Radiotherapy for Patients with Locally Recurrent Nasopharyngeal Carcinoma. PLoS ONE. 8(9). e73918–e73918. 43 indexed citations
19.
Ma, Xiumei & Yongrui Bai. (2012). IGF-1 activates the P13K/AKT signaling pathway via upregulation of secretory clusterin. Molecular Medicine Reports. 6(6). 1433–1437. 37 indexed citations
20.
Bai, Yongrui, Ming Ye, Hongbin Cao, et al.. (2012). Economic evaluation of radiotherapy for early breast cancer after breast-conserving surgery in a health resource-limited setting. Breast Cancer Research and Treatment. 136(2). 547–557. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026